Nature Communications (Apr 2024)

An individualized protein-based prognostic model to stratify pediatric patients with papillary thyroid carcinoma

  • Zhihong Wang,
  • He Wang,
  • Yan Zhou,
  • Lu Li,
  • Mengge Lyu,
  • Chunlong Wu,
  • Tianen He,
  • Lingling Tan,
  • Yi Zhu,
  • Tiannan Guo,
  • Hongkun Wu,
  • Hao Zhang,
  • Yaoting Sun

DOI
https://doi.org/10.1038/s41467-024-47926-w
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Pediatric papillary thyroid carcinomas (PPTCs) exhibit high inter-tumor heterogeneity and currently lack widely adopted recurrence risk stratification criteria. Hence, we propose a machine learning-based objective method to individually predict their recurrence risk. We retrospectively collect and evaluate the clinical factors and proteomes of 83 pediatric benign (PB), 85 pediatric malignant (PM) and 66 adult malignant (AM) nodules, and quantify 10,426 proteins by mass spectrometry. We find 243 and 121 significantly dysregulated proteins from PM vs. PB and PM vs. AM, respectively. Function and pathway analyses show the enhanced activation of the inflammatory and immune system in PM patients compared with the others. Nineteen proteins are selected to predict recurrence using a machine learning model with an accuracy of 88.24%. Our study generates a protein-based personalized prognostic prediction model that can stratify PPTC patients into high- or low-recurrence risk groups, providing a reference for clinical decision-making and individualized treatment.